CAR-T cell therapy development is a complex process that requires standardization.
Mark White
Advertisement
Mark White, PhD, is the associate director of Biopharma Product Marketing at Bio-Rad.
Articles by Mark White
Advertisement
Latest Updated Articles
Assessing the Quality of CAR-T Cells Using ddPCRPublished: March 15th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
2
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
3
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
4
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
5
